Patrick Gallagher
Corporate Officer/Principal bei SENSEI BIOTHERAPEUTICS, INC.
Vermögen: 34 130 $ am 30.04.2024
Aktive Positionen von Patrick Gallagher
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SENSEI BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01.06.2022 | - |
Karriereverlauf von Patrick Gallagher
Ehemalige bekannte Positionen von Patrick Gallagher
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Binney Street Partners, LLC | Corporate Officer/Principal | 01.10.2020 | 01.06.2022 |
Aquilo Partners LP
Aquilo Partners LP Investment ManagersFinance Aquilo Partners LP provides corporate finance, mergers & acquisitions and strategic advisory services to public and private life science companies. It also provides buyside M&A, sellside M&A, partnering and private placement. The company was founded by Brian Polzak, John Rumsey and James Zanze in 2001 and is located in San Francisco, CA. | Corporate Officer/Principal | 01.03.2018 | 01.01.2020 |
RADIUS HEALTH, INC. | Corporate Officer/Principal | 01.01.2016 | 01.01.2018 |
PFIZER, INC. | Vertrieb & Marketing | - | - |
AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Celexion LLC
Celexion LLC Pharmaceuticals: MajorHealth Technology Celexion LLC develops platform technologies and products in the pharmaceutical, industrial, agricultural and life science research sectors. The company was founded by Brian Baynes in 2009 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 06.09.2011 | - |
Ausbildung von Patrick Gallagher
Boston University | Graduate Degree |
Ohio Wesleyan University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Israel | 2 |
Operativ
Corporate Officer/Principal | 6 |
Sales & Marketing | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PFIZER, INC. | Health Technology |
SENSEI BIOTHERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Celexion LLC
Celexion LLC Pharmaceuticals: MajorHealth Technology Celexion LLC develops platform technologies and products in the pharmaceutical, industrial, agricultural and life science research sectors. The company was founded by Brian Baynes in 2009 and is headquartered in Cambridge, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Binney Street Partners, LLC | |
Aquilo Partners LP
Aquilo Partners LP Investment ManagersFinance Aquilo Partners LP provides corporate finance, mergers & acquisitions and strategic advisory services to public and private life science companies. It also provides buyside M&A, sellside M&A, partnering and private placement. The company was founded by Brian Polzak, John Rumsey and James Zanze in 2001 and is located in San Francisco, CA. | Finance |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Patrick Gallagher
- Erfahrung